TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A Cochrane review suggests zinc may shorten a cold by around two days, but researchers rated the evidence as low certainty and found no convincing reduction in overall symptom severity. A dietitian says lozenges started early may be more promising than tablets, while high doses can cause side effects and exceed recommended limits.
A 2024 Cochrane review found that zinc may shorten common-cold symptoms by about two days, according to registered dietitian Johannah Katz, but the evidence was rated low certainty and did not convincingly show that zinc reduces overall symptom severity. The findings suggest a possible modest benefit from using zinc after symptoms begin, while leaving questions about the best dose and safety.
Katz told Fit&Well that zinc may be more useful as a short-term response to a cold than as a routine immune supplement. She said the evidence is strongest when use begins early, ideally within 24 hours of the first symptoms. The review’s estimate of roughly two days is a possible average effect, not a guarantee that an individual’s illness will end sooner.
The report says evidence has favored zinc lozenges over swallowed tablets. Lozenges dissolve in the mouth and release zinc around the mouth and throat. Katz said both zinc acetate and zinc gluconate lozenges have shown benefit, with no significant difference between the two in a meta-analysis. She advised looking at the amount of elemental zinc—the zinc itself—rather than the total weight of the compound.
Doses used in trials showing possible benefits were often around 75 to 90 milligrams of elemental zinc daily, generally for less than two weeks, Katz said. Those amounts are above the US adult tolerable upper intake level of 40 mg daily, which includes zinc from food and supplements. The report also cites NHS advice not to take more than 25 mg of zinc supplements a day unless a doctor advises otherwise.
Potential Benefit Comes With Dose Risks
A cold has no cure, so even a possible reduction in symptom duration may interest people looking for ways to manage an illness. But the review’s low-certainty finding does not establish that zinc will help everyone, and the evidence did not convincingly show a meaningful reduction in overall symptom severity. The difference between a possible average benefit and a dependable treatment matters when people decide whether to use a supplement.
The doses associated with benefits also make safety relevant. Katz said zinc can cause nausea, stomach upset and a metallic taste. Long-term high-dose use can interfere with copper absorption and may impair immune function. Zinc can also interact with tetracycline and quinolone antibiotics and with penicillamine, so people taking medication should check with a pharmacist or healthcare professional before using it.
The report warns against intranasal zinc sprays and gels, which have been linked with potentially permanent loss of smell. That risk is distinct from the evidence discussed for lozenges and is a reason not to treat all zinc products as interchangeable.
As an affiliate, we earn on qualifying purchases.
What the Cold Studies Examined
Zinc is an essential mineral that supports normal immune function. The report describes possible antiviral effects in the mouth and throat as one explanation for why a lozenge might help, but researchers have not confirmed that mechanism. The proposed action should not be treated as proof that zinc prevents a cold virus from spreading or copying itself in people.
Katz characterized the Cochrane findings as “promising rather than definitive.” She said study results varied substantially in dose, formulation and design, contributing to the low certainty rating. The review also found that preventive zinc supplementation may have little or no effect on the likelihood of developing a cold, according to Katz; she sees the potential use as more closely tied to starting a short course once symptoms appear.
The supplied report also refers to a 2027 meta-analysis of seven trials that it says found lozenges containing more than 75 mg of zinc shortened colds by an average of 33% versus placebo. That date is later than the current date of October 2026, so the claim cannot be treated here as an already published finding without confirmation. The 2024 Cochrane review is the dated evidence cited in the report that can be placed in the timeline.
zinc acetate zinc gluconate lozenges
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Dose and Benefit Remain Unsettled
The available summary does not establish which exact zinc dose or lozenge schedule offers the best balance of benefit and risk. Katz said studies differed in their doses, formulations and designs, and the Cochrane review rated the evidence low certainty. It is also unclear which groups, if any, are more likely to benefit.
The report’s cited estimate of about two days is not a promise for an individual, and the review did not find convincing evidence of reduced overall symptom severity. The proposed antiviral mechanism has not been confirmed. The claimed 2027 meta-analysis is also future-dated relative to October 2026 and needs checking before its result can be relied on.
As an affiliate, we earn on qualifying purchases.
Check Guidance Before Using Zinc
Readers considering zinc for cold symptoms should compare the product’s elemental-zinc amount with local health guidance and discuss higher-dose use with a pharmacist or healthcare professional, particularly if they take medication. Katz cautioned against routinely self-supplementing at trial-level doses without that check. The report offers no clinical recommendation that applies to every person.
Further clarity depends on better-designed studies that compare formulations and doses and report both symptom duration and severity. The publication and findings of the cited 2027 meta-analysis should also be verified. Until then, the most supportable conclusion is limited: early zinc lozenges may shorten a cold for some people, but the benefit is uncertain and the studied doses raise safety concerns.
As an affiliate, we earn on qualifying purchases.
Key Questions
Can zinc make a cold go away faster?
A 2024 Cochrane review found zinc may shorten cold symptoms by around two days, but the evidence was rated low certainty. It is not a guaranteed effect, and the review did not find convincing evidence that zinc reduces overall symptom severity.
Which zinc form has the better evidence?
The Fit&Well report says evidence is stronger for lozenges than for swallowed tablets. Katz said both zinc acetate and zinc gluconate lozenges have shown benefit, with no significant difference between them in a meta-analysis.
When would zinc need to be started?
Katz said the strongest evidence supports starting zinc within 24 hours of the first symptoms. The source does not establish a single proven schedule for all products.
Are the doses studied considered low risk?
Not necessarily. Katz said trials showing possible benefit commonly used 75 to 90 mg of elemental zinc daily, above the US adult upper intake level of 40 mg per day. NHS guidance cited in the report advises no more than 25 mg of zinc supplements daily unless a doctor advises otherwise. Check with a pharmacist or healthcare professional before using high doses.
Can zinc cause side effects or interact with medicines?
Katz cited nausea, stomach upset and an unpleasant or metallic taste as common side effects. Zinc can interact with some antibiotics and penicillamine; people taking medication should ask a pharmacist or healthcare professional about possible interactions. The report also advises avoiding intranasal zinc products because they have been linked with potentially permanent loss of smell.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
